A Study of Safety and Effectiveness of Ustekinumab in Patients With Moderate to Severe Active Crohn's Disease Who Have Been Previously Treated With Anti-TNF Therapy
This study has been completed.
Study NCT00771667
Information provided by Centocor, Inc.
First Received on October 10, 2008.
Last Updated on March 26, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
